Government of Laos Report issue

Government Phase 2 Phase 3
Founded: Vientiane Lao People's Democratic Republic (1991)

Organization Overview

First Clinical Trial
2018
NCT03343431
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR | Lao PDR: National Institute of Public Health (NIOPH) | Ministry of Health, Lao PDR | National Center for Laboratory and Epidemiology, Lao PDR | National Institute of Public Health, Vientiane, Laos | National Tobacco Control Committee, Lao PDR

Active Ingredients

Drugs in Phase 3 Trials (3)

albendazole (Albenza) (1 trial)

ivermectin (stromectol) (2 trials)

tenofovir (viread) (1 trial)

Drugs in Phase 2 Trials (2)

moxidectin (1 trial)

nicotine (nicorette) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis B (Phase 3)

Strongyloidiasis (Phase 2)

Trichuriasis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 5